Advertisement

Research Article Free access | 10.1172/JCI111941

Plasma immunoreactive gamma melanotropin in patients with idiopathic hyperaldosteronism, aldosterone-producing adenomas, and essential hypertension.

G T Griffing, B Berelowitz, M Hudson, R Salzman, J A Manson, S Aurrechia, J C Melby, R C Pedersen, and A C Brownie

Find articles by Griffing, G. in: PubMed | Google Scholar

Find articles by Berelowitz, B. in: PubMed | Google Scholar

Find articles by Hudson, M. in: PubMed | Google Scholar

Find articles by Salzman, R. in: PubMed | Google Scholar

Find articles by Manson, J. in: PubMed | Google Scholar

Find articles by Aurrechia, S. in: PubMed | Google Scholar

Find articles by Melby, J. in: PubMed | Google Scholar

Find articles by Pedersen, R. in: PubMed | Google Scholar

Find articles by Brownie, A. in: PubMed | Google Scholar

Published July 1, 1985 - More info

Published in Volume 76, Issue 1 on July 1, 1985
J Clin Invest. 1985;76(1):163–169. https://doi.org/10.1172/JCI111941.
© 1985 The American Society for Clinical Investigation
Published July 1, 1985 - Version history
View PDF
Abstract

A non-ACTH aldosterone-stimulating factor(s) has been implicated in the pathogenesis of idiopathic hyperaldosteronism (IHA). Although this factor has not been fully characterized, some evidence suggests that it may be related to a pro-gamma-melanotropin (pro-gamma-MSH), derived from the NH2-terminal region of pro-opiomelanocortin. In the present study, plasma immunoreactive (IR-) gamma-MSH levels at 0800 h in patients with IHA were evaluated (90 +/- 17 fmol/ml; range: 13-173 fmol/ml) and found to be significantly higher (P less than 0.05) than those in subjects with aldosterone-producing adenomas (33 +/- 8 fmol/ml), essential hypertension (33 +/- 6 fmol/ml), and normotensive controls (19 +/- 2 fmol/ml). Seven of nine IHA subjects had circulating IR-gamma-MSH levels above the normal range (greater than 35 fmol/ml). In plasmas sampled at 1200 h, IR-gamma-MSH was significantly higher in patients with IHA (95 +/- 26 fmol/ml) and adenomas (63 +/- 23 fmol/ml), as compared with essential hypertensives (31 +/- 6 fmol/ml) and normotensives (19 +/- 3 fmol/ml). Mean plasma IR-ACTH, plasma cortisol, and urinary cortisol levels did not differ significantly between any of these groups. In order to evaluate the effect of a pro-gamma-MSH in vitro, adrenal adenoma tissue was obtained from two patients, one with elevated IR-gamma-MSH (61 fmol/ml) and a second with low IR-gamma-MSH (12 fmol/ml). Aldosterone secretion by dispersed adenoma cells from the former, but not the latter, underwent a fourfold dose-dependent (10(-14)-10(-9) M) increase in response to human Lys-gamma 3-MSH. These data suggest that a pro-gamma-MSH may be implicated as a pathogenic factor in a subset of patients with primary aldosteronism, particularly among those differentially diagnosed as having IHA.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (July 1, 1985): No description
Advertisement
Advertisement